Comparison

MCI-225 European Partner

Item no. ALO-M-190-5mg
Manufacturer Alomone
CASRN 135991-48-9
Amount 5 mg
Quantity options 10 mg 25 mg 50 mg 5 mg
Category
Type Small Molecules
Format Lyophilized
Specific against other
Purity >98%
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Shipping Condition Room temperature
Available
Manufacturer - Type
Non Antibodies
Manufacturer - Category
S. Molecules
Manufacturer - Targets
5-HT3A receptor, NET transporter
Country of Origin
Israel
Shipping Temperature
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C
Storage Conditions
Storage as Solution: Up to four weeks at 4°C or three months at -20°C. - Storage after Reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods (up to 6 months), small aliquots should be stored at -20°C. We do not recommend storing the product in working solutions for longer than a few days. Avoid multiple freeze-thaw cycles.
Molecular Weight
328, 4
Manufacturer - Format
Lyophilized powder.
Short description
A Potent Antagonist of 5-HT3 Channels and a Selective Noradrenaline Reuptake Inhibitor
Description
DDP-225 - A Potent Antagonist of 5-HT3 Channels and a Selective Noradrenaline Reuptake Inhibitor
Reconstitution
30 mM in DMSO. Centrifuge all product preparations before use (10000 x g 5 min).
PH
7, 4
UNSPSC
41116134
Effective Concentration
10 nM - 1 µM.
Activity
MCI-225 shows high affinity for the 5-HT3 receptor, Ki less than 100 nmol/L1.
Solubility
30 mM in DMSO. Centrifuge all product preparations before use (10000 x g 5 min).
Bioassay tested
Yes
Chemical Name
4-(2-fluorophenyl)-6-methyl-2-piperazin-1-ylthieno[2, 3-d]pyrimidine.
Scientific Background
MCI-225 is a psychoactive compound, a thienopyrimidine analogue that acts as a selective noradrenaline (NA) reuptake inhibitor with 5-HT3 channel blocking action. The compound demonstrates antidepressant-like activity with primary activity in the central nervous system.Several studies have shown that MCI-225 exhibits improvement in amnesia in scopolamine treated rats and in basal forebrain lesion rats. Acute administration of MCI-225 inhibits the rise of threshold induced by footshock stress1.It has been suggested that MCI-225 may affect attention, learning and memory2.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Delivery expected until 1/8/2026 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close